Characteristic clinical and biochemical profile of recurrent calcium-oxalate nephrolithiasis in patients with metabolic syndrome

Nephrology Dialysis Transplantation

Volumn 26, Issue 7, 2011, Pages 2256-2263

  Rendina, Domenico ^a   De Filippo, Gianpaolo ^a   Zampa, Giorgia ^a   Muscariello, Riccardo ^a   Mossetti, Giuseppe ^a   Strazzullo, Pasquale ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

calcium oxalate nephrolithiasis; ion activity product; metabolic syndrome; sodium intake; sodium restricted diet

Indexed keywords

CALCIUM; CITRIC ACID; OXALIC ACID; SODIUM;

ADULT; ARTICLE; CALCIUM EXCRETION; CALCIUM OXALATE STONE; CONTROLLED STUDY; EATING HABIT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NEPHROLITHIASIS; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; SODIUM EXCRETION; SODIUM RESTRICTION;

ADULT; CALCIUM; CALCIUM OXALATE; DIET, SODIUM-RESTRICTED; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NEPHROLITHIASIS; OXALATES; PROGNOSIS; RECURRENCE; RISK FACTORS;

EID: 79959930124     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq664     Document Type: Article

References (65)

1. Cornier MA, Dabelea D, Hernandez TL et al. The metabolic syndrome. Endocr Rev 2008; 29: 777-822.
2. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752. (Pubitemid 41532612)
3. Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140: 167-174.
4. Locatelli F, Pozzoni P, Del Vecchio L. Renal manifestations in the metabolic syndrome. J Am Soc Nephrol 2006; 17: S81-S85.
5. Rendina D, Mossetti G, De Filippo G et al. Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and obesity. Nephrol Dial Transplant 2009; 24: 900-906.
6. West B, Luke A, Durazo-Arvizu RA et al. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Am J Kidney Dis 2008; 51: 741-747. (Pubitemid 351626247)
7. Cappuccio FP, Strazzullo P, Mancini M. Kidney stones and hypertension: an independent clinical association in a population-based study. BMJ 1990; 300: 1234-1236. (Pubitemid 20170675)
8. Curhan GC, Willett WC, Rimm EB et al. Body size and risk of kidney stones. J Am Soc Nephrol 1998; 9: 1645-1652. (Pubitemid 28405072)
9. Tisler A, Pierratos A, Honey JD et al. High urinary excretion of uric acid combined with high excretion of calcium links kidney stone disease to familial hypertension. Nephrol Dial Transplant 2002; 17: 253-259. (Pubitemid 34157139)
10. Abate N, Chandalia M, Cabo-Chan AVJr et al. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 2004; 65: 386-392. (Pubitemid 38130632)
11. Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 2005; 68: 1230-1235. (Pubitemid 43246441)
12. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA 2005; 293: 455-462.
13. Taylor EN, Mount DB, Forman JP et al. Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors. Am J Kidney Dis 2006; 47: 780-789.
14. Maalouf NM, Cameron MA, Moe OWet al. Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2007; 2: 883-888.
15. Cupisti A, Meola M, D'Alessandro C et al. Insulin resistance and low urinary citrate excretion in calcium stone formers. Biomed Pharmacother 2007; 61: 86-90. (Pubitemid 46185875)
16. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 2005; 115: 2598-2608. (Pubitemid 41434382)
17. Borghi L, Schianchi T, Meschi T et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002; 346: 77-84. (Pubitemid 34438897)
18. Strazzullo P, Vuotto P. Genetics of stone forming diseases. In: F Flinter, RM Eamonn, A Saggar-Malik (eds). Genetics of Renal Disease. Oxford: Oxford University Press, 2004; 580.
19. Amato M, Lusini ML, Nelli F. Epidemiology of nephrolithiasis today. Urol Int 2004; 721-5.
20. Parmar MS. Kidney stones. BMJ 2004; 328: 1420-1424. (Pubitemid 38789199)
21. Serio A, Fraioli A. Epidemiology of nephrolithiasis. Nephron 1999; 81: S26-S30.
22. Smulders YM, Frissen PH, Slaats EH et al. Renal tubular acidosis. Pathophysiology and diagnosis. Arch Intern Med 1996; 156: 1629-1636. (Pubitemid 26287118)
23. Levy FL, Adams-Huet B, Pak CY. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 1995; 98: 50-59.
24. Pak CY. Pharmacotherapy of kidney stones. Expert Opin Pharmacother 2008; 9: 1509-1518. (Pubitemid 352005912)
25. Siener R, Hesse A. The effects of different diets on urine composition and the risk of calcium oxalate crystallisation in healthy subjects. Eur Urol 2002; 42: 289-296. (Pubitemid 35024241)
26. Cook NR, Cutler JA, Obarzanek E et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007; 334: 885-893.
27. Tiselius HG, Ackermann D, Alken P et al. Working Party on Lithiasis, European Association of Urology. Guidelines on urolithiasis. Eur Urol 2001; 40: 362-471.
28. Rendina D, Mossetti G, Viceconti R et al. Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone forming patients. Urology 2004; 64: 833-838. (Pubitemid 39446084)
29. Pak CY, Poindexter JR, Adams-Huet B et al. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 2003; 115: 26-32. (Pubitemid 36831118)
30. Strazzullo P, Barba G, Vuotto P et al. Past history of nephrolithiasis and incidence of hypertension in men: a reappraisal based on the re- sults of the Olivetti Prospective Heart Study. Nephrol Dial Transplant 2001; 16: 2232-2235. (Pubitemid 33062149)
31. Yang Q, Khoury MJ, Rodriguez C et al. Family history score as a predictor of breast cancer mortality: prospective data from the cancer prevention study II, United States, 1982-1991. Am J Epidemiol 1998; 147: 652-659. (Pubitemid 28180308)
32. Mossetti G, Rendina D, Viceconti R et al. The relationship of 3' vitamin D receptor haplotypes to urinary supersaturation of calcium oxalate salts and to age at onset and familial prevalence of nephrolithiasis. Nephrol Dial Transplant 2004; 19: 2259-2265. (Pubitemid 39214119)
33. Hess B, Tiselius HG. Physical-chemical process in kidney stone formation. In: FL Coe, MJ Favus (eds). Disorders of Bone and Mineral Metabolism. Philadelphia: Lippincott Williams & Wilkins, 2002; 619-628.
34. Golden SH, Robinson KA, Saldanha I et al. Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab 2009; 94: 1853-1878.
35. Rule AD, Bergstralh EJ, Melton LJ 3rd et al. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 804-811.
36. Brown IJ, Tzoulaki I, Candeias Vet al. Salt intakes around the world: implications for public health. Int J Epidemiol 2009; 38: 791-813.
37. Lutsey PL, Steffen LM, Stevens J. Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study. Circulation 2008; 117: 754-761. (Pubitemid 351640676)
38. Panagiotakos DB, Pitsavos C, Skoumas Y et al. The association between food patterns and the metabolic syndrome using principal components analysis: The ATTICA Study. J Am Diet Assoc 2007; 107: 979-987. (Pubitemid 46764587)
39. Leite ML, Nicolosi A. Dietary patterns and metabolic syndrome factors in a non-diabetic Italian population. Public Health Nutr 2009; 12: 1494-1503.
40. Williams DE, Prevost AT, Whichelow MJ et al. A cross-sectional study of dietary patterns with glucose intolerance and other features of the metabolic syndrome. Br J Nutr 2000; 83: 257-266. (Pubitemid 30125221)
41. Sonnenberg L, Pencina M, Kimokoti R et al. Dietary patterns and the metabolic syndrome in obese and non-obese Framingham women. Obes Res 2005; 13: 153-162.
42. Yoo S, Nicklas T, Baranowski T et al. Comparison of dietary intakes associated with metabolic syndrome risk factors in young adults: the Bogalusa Heart Study. Am J Clin Nutr 2004; 80: 841-848. (Pubitemid 41202080)
43. Deshmukh-Taskar PR, O'Neil CE, Nicklas TA et al. Dietary patterns associated with metabolic syndrome, sociodemographic and lifestyle factors in young adults: the Bogalusa Heart Study. Public Health Nutr 2009; 12: 2493-2503.
44. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of followup. J Am Soc Nephrol 2004; 15: 3225-3232. (Pubitemid 39578855)
45. Pak CY. Kidney stones. Lancet 1998; 351: 1797-1801. (Pubitemid 28269199)
46. Esposito K, Marfella R, Ciotola M et al. Effect of a Mediterraneanstyle diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004; 292: 1440-1446. (Pubitemid 39258336)
47. Strazzullo P, Barbato A, Galletti F et al. Abnormalities of renal sodium handling in the metabolic syndrome. Results of the Olivetti Heart Study. J Hypertens 2006; 24: 1633-1639. (Pubitemid 44162466)
48. Strazzullo P, Barba G, Cappuccio FP et al. Altered renal sodium handling in men with abdominal adiposity: a link to hypertension. J Hypertens 2001; 19: 2157-2164. (Pubitemid 33135236)
49. Sarafidis PA, Bakris GL. The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance? Am J Nephrol 2007; 27: 44-54. (Pubitemid 46364540)
50. ter Maaten JC, Bakker SJ, Sern EH et al. Insulin's acute effects on glomerular filtration rate correlate with insulin sensitivity whereas insulin's acute effects on proximal tubular sodium reabsorption correlation with salt sensitivity in normal subjects. Nephrol Dial Transplant 1999; 14: 2357-2363. (Pubitemid 29462472)
51. Rebsomen L, Khammar A, Raccah D et al. C-Peptide effects on renal physiology and diabetes. Exp Diabetes Res 2008; doi:10.1155/2008/ 281536.
52. Powell CR, Stoller ML, Schwartz BF et al. Impact of body weight on urinary electrolytes in urinary stone formers. Urology 2000; 55: 825-830. (Pubitemid 30330779)
53. Hoffmann IS, Cubeddu LX. Increased blood pressure reactivity to dietary salt in patients with the metabolic syndrome. J Hum Hypertens 2007; 21: 438-444. (Pubitemid 46813593)
54. Hoenderop JG, Willems PH, Bindels RJ. Toward a comprehensive molecular model of active calcium reabsorption. Am J Physiol Renal Physiol 2000; 278: F352-F360. (Pubitemid 30163233)
55. Loffing J, Kaissling B. Sodium and calcium transport pathways along the mammalian distal nephron: from rabbit to human. Am J Physiol Renal Physiol 2003; 284: F628-F643. (Pubitemid 36336969)
56. Aronson PS. Essential roles of CFEX-mediated Cl(+)-oxalate exchange in proximal tubule NaCl transport and prevention of urolithiasis. Kidney Int 2006; 70: 1207-1213. (Pubitemid 44435171)
57. Taylor EN, Curhan GC. Determinants of 24-hour urinary oxalate excretion. Clin J Am Soc Nephrol 2008; 3: 1453-1460.
58. Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis 2006; 48: 905-915. (Pubitemid 44895373)
59. Hatch M, Freel RW. The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis. Semin Nephrol 2008; 28: 143-151. (Pubitemid 351400302)
60. Krick W, Schnedler N, Burckhardt G et al. The ability of sat-1 to transport sulfate, bicarbonate, or oxalate under physiological conditions. Am J Physiol Renal Physiol 2009; 297: F145-F154.
61. Palmer LG, Frindt G. Na+ and K+ transport by the renal connecting tubule. Curr Opin Nephrol Hypertens 2007; 16: 477-483. (Pubitemid 47254700)
62. Nouvenne A, Meschi T, Guerra A et al. Diet to reduce mild hyperoxaluria in patients with idiopathic calcium oxalate stone formation: a pilot study. Urology 2009; 73: 725-730.
63. Scales CD Jr, Curtis LH, Norris RD et al. Changing gender prevalence of stone disease. J Urol 2007; 177: 979-982. (Pubitemid 46216342)
64. Lieske JC, Pe? de la Vega LS, Slezak JM et al. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int 2006; 69: 760-764. (Pubitemid 43237647)
65. Maalouf NM, Sakhaee K, Parks JH et al. Association of urinary pH with body weight in nephrolithiasis. Kidney Int 2004; 65: 1422-1425 (Pubitemid 38406983)